A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 113.09
GOOG 783.01
MSFT 57.95
FB 128.69
BAC 15.29

Recently Added

EAT 52.30
MDM 5.28
ACBI 14.77
QHC 6.14
LOAN 7.38

Gaining Speed

EAT 52.30
MDM 5.28
MDRX 13.07
KMX 53.70
VPIG 0.36

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!